Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Japanese (NIKKEI) Clinical Research and Equipment Industry Analysis

UpdatedDec 21, 2024
DataAggregated Company Financials
Companies15
  • 7D-2.9%
  • 3M-0.04%
  • 1Y-13.7%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has dropped 3.5%, driven by CellSource declining 17%. Overall the industry is down 15% in 12 months. Looking forward, earnings are forecast to grow by 16% annually.

Industry Valuation and Performance

Has the Japanese Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 21 Dec 2024JP¥158.3bJP¥62.0bJP¥440.7m17.1x359.1x2.6x
Mon, 18 Nov 2024JP¥153.8bJP¥62.6bJP¥1.3b19.9x115.3x2.5x
Wed, 16 Oct 2024JP¥151.8bJP¥61.5bJP¥1.8b20.8x82.5x2.5x
Fri, 13 Sep 2024JP¥157.5bJP¥61.6bJP¥2.1b18.3x76.2x2.6x
Sun, 11 Aug 2024JP¥140.9bJP¥61.5bJP¥2.0b19x69.6x2.3x
Tue, 09 Jul 2024JP¥164.2bJP¥61.8bJP¥3.2b25.8x50.7x2.7x
Thu, 06 Jun 2024JP¥162.5bJP¥61.8bJP¥3.3b25.2x49.6x2.6x
Sat, 04 May 2024JP¥182.6bJP¥62.3bJP¥3.3b14x55.5x2.9x
Mon, 01 Apr 2024JP¥234.9bJP¥155.4bJP¥8.6b14x27.3x1.5x
Wed, 28 Feb 2024JP¥237.5bJP¥155.3bJP¥8.7b14.6x27.3x1.5x
Fri, 26 Jan 2024JP¥228.7bJP¥167.1bJP¥8.5b15.4x26.9x1.4x
Sun, 24 Dec 2023JP¥222.2bJP¥167.1bJP¥8.5b14.8x26.1x1.3x
Tue, 21 Nov 2023JP¥236.0bJP¥167.4bJP¥8.7b15.1x27.2x1.4x
Thu, 19 Oct 2023JP¥230.6bJP¥179.3bJP¥12.8b14.3x18.1x1.3x
Sat, 16 Sep 2023JP¥257.5bJP¥179.3bJP¥12.8b15.7x20.1x1.4x
Mon, 14 Aug 2023JP¥272.4bJP¥180.0bJP¥13.7b17.6x19.8x1.5x
Wed, 12 Jul 2023JP¥279.5bJP¥178.5bJP¥16.2b16.8x17.2x1.6x
Fri, 09 Jun 2023JP¥282.6bJP¥178.3bJP¥16.2b16.9x17.4x1.6x
Sun, 07 May 2023JP¥288.7bJP¥174.9bJP¥16.5b16.6x17.5x1.7x
Tue, 04 Apr 2023JP¥310.5bJP¥171.9bJP¥13.3b17.2x23.4x1.8x
Thu, 02 Mar 2023JP¥314.6bJP¥171.6bJP¥13.2b17.4x23.8x1.8x
Sat, 28 Jan 2023JP¥295.2bJP¥166.0bJP¥16.1b15.7x18.3x1.8x
Mon, 26 Dec 2022JP¥290.8bJP¥166.1bJP¥16.2b15.6x18x1.8x
Wed, 23 Nov 2022JP¥323.8bJP¥165.5bJP¥16.0b15.6x20.2x2x
Fri, 21 Oct 2022JP¥318.9bJP¥160.1bJP¥12.4b16.1x25.8x2x
Sun, 18 Sep 2022JP¥318.4bJP¥160.1bJP¥12.4b18.8x25.7x2x
Tue, 16 Aug 2022JP¥309.3bJP¥159.8bJP¥12.6b18.1x24.5x1.9x
Thu, 14 Jul 2022JP¥290.5bJP¥152.8bJP¥10.9b17.2x26.7x1.9x
Sat, 11 Jun 2022JP¥268.6bJP¥152.7bJP¥10.9b17.9x24.7x1.8x
Mon, 09 May 2022JP¥243.3bJP¥152.3bJP¥11.4b20.3x21.4x1.6x
Wed, 06 Apr 2022JP¥266.2bJP¥144.9bJP¥10.6b22x25.1x1.8x
Fri, 04 Mar 2022JP¥252.2bJP¥144.7bJP¥10.5b19.2x24x1.7x
Sun, 30 Jan 2022JP¥226.8bJP¥136.1bJP¥6.8b21.2x33.6x1.7x
Tue, 28 Dec 2021JP¥289.3bJP¥136.0bJP¥6.8b23.2x42.9x2.1x
Price to Earnings Ratio

42.9x


Total Market Cap: JP¥289.3bTotal Earnings: JP¥6.8bTotal Revenue: JP¥136.0bTotal Market Cap vs Earnings and Revenue0%0%0%
Japanese Clinical Research and Equipment Industry Price to Earnings3Y Average 38.3x202220232024
Current Industry PE
  • Investors are optimistic on the Japanese Life Sciences Tools and Services industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 360x which is higher than its 3-year average PE of 38.3x.
  • The 3-year average PS ratio of 1.9x is lower than the industry's current PS ratio of 2.6x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have declined 60% per year over the last three years,
  • Revenues have also declined 23% per year.
  • This means overall sales from these companies are declining and profits are subsequently falling as well.

Industry Comparison

How does Japanese Clinical Research and Equipment compare with similar industries?

JP Market-1.46%
Healthcare-0.72%
Life Sciences-2.92%
Clinical Research and Equipment-2.92%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
2395 Shin Nippon Biomedical LaboratoriesJP¥1.60k1.5%
+JP¥957.5m		-4.2%PE17.1x
2309 CMIC HOLDINGSJP¥2.64k0.2%
+JP¥84.5m		26.6%PE8.4x
7079 WDB cocoJP¥3.50k0.9%
+JP¥72.1m		-23.3%PE8.9x
4583 Chiome BioscienceJP¥235.000.4%
+JP¥62.4m		80.8%PS25.3x
6090 Human Metabolome TechnologiesJP¥607.000.2%
+JP¥5.9m		0.2%PE14.6x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4880

JP¥828.00

CellSource

7D

-16.8%

1Y

-38.0%

We Think That There Are More Issues For CellSource (TSE:4880) Than Just Sluggish Earnings

Dec 20
We Think That There Are More Issues For CellSource (TSE:4880) Than Just Sluggish Earnings

4583

JP¥235.00

Chiome Bioscience

7D

0.4%

1Y

80.8%

2395

JP¥1,604.00

Shin Nippon Biomedical Laboratories

7D

1.5%

1Y

-4.2%

Shin Nippon Biomedical Laboratories (TSE:2395) Will Pay A Dividend Of ¥30.00

Dec 19
Shin Nippon Biomedical Laboratories (TSE:2395) Will Pay A Dividend Of ¥30.00

4572

JP¥279.00

Carna Biosciences

7D

-10.3%

1Y

-44.6%

7707

JP¥227.00

Precision System Science

7D

-5.4%

1Y

-10.3%

2397

JP¥638.00

DNA Chip Research

7D

-4.9%

1Y

-8.9%

4892

JP¥452.00

Cyfuse Biomedical K.K

7D

-3.6%

1Y

-41.3%

Is Cyfuse Biomedical K.K (TSE:4892) Using Too Much Debt?

Dec 04
Is Cyfuse Biomedical K.K (TSE:4892) Using Too Much Debt?

130A

JP¥695.00

Veritas In Silico

7D

-12.0%

1Y

n/a

4570

JP¥452.00

Immuno-Biological Laboratories

7D

-3.6%

1Y

-1.5%

7079

JP¥3,500.00

WDB coco

7D

0.9%

1Y

-23.3%

Shareholders Will Be Pleased With The Quality of WDB coco's (TSE:7079) Earnings

Nov 20
Shareholders Will Be Pleased With The Quality of WDB coco's (TSE:7079) Earnings

2370

JP¥37.00

MEDINET

7D

-2.6%

1Y

-14.0%

6090

JP¥607.00

Human Metabolome Technologies

7D

0.2%

1Y

0.2%

2309

JP¥2,644.00

CMIC HOLDINGS

7D

0.2%

1Y

26.6%